BLRX
Bioline RX Ltd Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website biolinerx.com
- Employees(FY) 49
- ISIN US09071M2052
Performance
-6.58%
1W
+0.09%
1M
-48.8%
3M
-65.59%
6M
-59.24%
YTD
-57.33%
1Y
Profile
BioLineRx Ltd., a pre-commercial-stage biopharmaceutical company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in patients with acute respiratory distress syndrome secondary to COVID-19 and other respiratory viral infections, as well as for the treatment of solid tumors and acute myeloid leukemia. It is also developing AGI-134, an immuno-oncology agent, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; and MD Anderson Cancer Center to investigate the combination of Motixafortide with KEYTRUDA (pembrolizumab) in pancreatic cancer, as well as licensing arrangement with Perrigo Company plc for over-the-counter sale of BL-5010. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Modi'in, Israel.
Technical Analysis of BLRX 2024-05-10
Overview:
In the last 5 trading days, BLRX has shown a downward trend in its stock price, accompanied by decreasing trading volumes. The moving averages indicate a bearish sentiment, with the stock price consistently below the short-term moving averages. Momentum indicators suggest a weakening trend, while volatility indicators show a narrowing ...
Recent News & Updates
- 2023-07-18 03:22
3 Smart Penny Stocks with Huge Potential(Yahoo Finance)
- 2023-07-16 19:00
- 2023-06-29 02:00
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023(Yahoo Finance)
- 2023-06-06 17:25
BLRX: First Quarter Results(Yahoo Finance)
- 2023-05-23 19:00
- 2023-05-16 19:00
- 2023-05-04 01:56
7 High-Potential Penny Stocks in the Biotech Sector(Yahoo Finance)
- 2023-04-24 19:00
- 2023-04-16 23:00
- 2023-04-04 08:21
The 3 Best Biotech Stocks Under $1 to Buy for April(Yahoo Finance)
- 2023-03-23 19:15
- 2023-03-22 23:42
BLRX: Confidence in a Strong Launch(Yahoo Finance)
- 2023-03-21 19:00
- 2023-03-14 19:00
- 2023-03-05 18:00
- 2023-01-03 18:00
- 2022-12-19 23:36
- 2022-12-19 18:00
- 2022-12-04 15:00
BLRX: Self-Commercialization in the US(Yahoo Finance)
- 2022-11-28 03:30
- 2022-11-14 18:00
- 2022-11-10 03:30
- 2022-11-09 18:00
- 2022-11-04 04:30
- 2022-11-02 21:11
- 2022-11-01 21:21
BLRX: Cast Off the Bowlines: Aphexda Commercialization(Yahoo Finance)
- 2022-09-26 19:00
- 2022-09-18 20:00
BioLineRx Announces $15 Million Registered Direct Offering(Yahoo Finance)
- 2022-09-15 00:38
- 2022-09-14 19:00